SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
New Anti-cancer Agent Can Overcome Resistance To Drugs, Says Study
February 25, 2008
 · 
1 min read
Drug Development
Can Robotic Machinery Predict What Is Toxic? Lab Rats May Get A Reprieve Some Day
February 18, 2008
 · 
1 min read
Drug Development
Transplanted Liver Lining Cells May Cure Hemophilia
February 15, 2008
 · 
1 min read
Drug Development
Artificial Sweeteners Linked To Weight Gain
February 11, 2008
 · 
1 min read
Drug Development
Experimental Anti-cancer Drug Reduces Tumor Growth And Tumor Volume In Mice
February 11, 2008
 · 
1 min read
Drug Development
Depressed Mice Reveal Critical Chemical Pathway For Treatment, Duke University Medical Center Study
February 8, 2008
 · 
1 min read
Drug Development
Chronic Drinking Can Lead To Severe Pneumonia After Surgery, Rodent Study Shows
February 7, 2008
 · 
1 min read
Drug Development
Giving Mice A Cold Virus Offers Hope Of New Asthma Treatments
February 7, 2008
 · 
1 min read
Drug Development
Rodent Study Shows That Chronic Drinking Can Lead To Severe Pneumonia After Surgery
February 4, 2008
 · 
1 min read
Drug Development
University of Southern California Experimental Vaccine Halts Prostate Cancer in Mice
February 1, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency
June 2, 2021
 · 
6 min read
Drug Development
Alpine Immune Sciences Presents ALPN-303 Data During the 2021 EULAR Virtual Meeting
June 2, 2021
 · 
3 min read
Drug Development
Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease
June 2, 2021
 · 
6 min read
Drug Development
Severe Heart Failure Treatment: FineHeart Successfully Raises €15 million Series B funding With Industrial and Independent Investors
June 1, 2021
 · 
7 min read
Drug Development
Recce Pharmaceuticals Announces Lead Synthetic Anti-infective RECCE® 327 Demonstrates World First Multiple Mechanisms of Action against E. coli bacteria
June 1, 2021
 · 
7 min read
Drug Development
Polyphor’s Balixafortide Demonstrates Consistent Dual Action Anti-Viral and Anti-Inflammatory Activity in COVID-19 Preclinical Trials
June 1, 2021
 · 
5 min read
Drug Development
Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology
May 27, 2021
 · 
4 min read
Business
Tectonic Therapeutic Appoints Peter McNamara, PhD Senior Vice President, Head of Research
May 27, 2021
 · 
3 min read
Drug Development
AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on SPX-1009 Compound Proving Suppression of Melanoma Cells
May 26, 2021
 · 
4 min read
Drug Development
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
May 26, 2021
 · 
7 min read
Drug Development
Altimmune Demonstrates Strong Neutralization of South African Variant in Preclinical Study of Intranasal AdCOVID™
May 26, 2021
 · 
6 min read
Drug Development
Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043
May 24, 2021
 · 
10 min read
Drug Development
Creative Medical Technology Holdings Expands Neurological Application of ImmCelz® into Parkinson’s Disease
May 24, 2021
 · 
3 min read
Drug Development
Humacyte Presents Advances in Whole-Lung Engineering
May 21, 2021
 · 
10 min read
Drug Development
Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual CongressNX-5948, a potent selective degrader of BTK, significantly reduces inflammation in a model of autoimmune disease
May 21, 2021
 · 
5 min read
Drug Development
IconOVir Bio Announces Preclinical Proof-of-Concept Data for Proprietary Mutations Designed to Improve Selectivity of Novel Oncolytic Viruses, Including Lead Product Candidate ICVB-1042
May 20, 2021
 · 
5 min read
Drug Development
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing
May 20, 2021
 · 
13 min read
Drug Development
Xilio Therapeutics to Present Preclinical Data Highlighting Anti-Tumor Activity and Tolerability of XTX202 at the 2021 ASCO Annual Meeting
May 20, 2021
 · 
4 min read
Drug Development
Avidity Biosciences Announces Updates on the Pipeline and Platform at Virtual Investor and Analyst Event
May 19, 2021
 · 
6 min read
Drug Development
Delix Therapeutics Retains KCSA Strategic Communications
May 19, 2021
 · 
4 min read
Load More